Edgewell Personal Care (EPC) FY2019 results: revenue $2.1 billion, down 4.2% on the year
Edgewell Personal Care Co. (EPC) reported revenue of $2.1 billion for fiscal 2019, the year ended 30 September 2019, down 4.2% on the year before. Net income was -$372 million, and diluted earnings per share $-6.88. The figures are the company's own, from the 10-K it filed with the SEC on 26 November 2019.
Revenue
$2.1 billion
-4.2% on the year
FY2012FY2019
Operating margin
11.4%
FY2012FY2019
Net income
-$372 million
FY2012FY2019
Diluted EPS
-$6.88
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
2,141
2,234
2,298
-4.2%
Cost of revenue
1,174
1,202
1,172
-2.3%
Gross profit
967
1,033
1,126
-6.4%
Gross margin
45.1%
46.2%
49.0%
Research and development
53.5
61.1
67.6
-12.4%
Operating income
244
n/a
n/a
Operating margin
11.4%
n/a
n/a
Interest expense
62.6
68.0
69.2
-7.9%
Pre-tax income
-390
164
-52.9
Income tax
-18.1
60.5
-58.6
Effective tax rate
n/a
36.9%
n/a
Net income
-372
103
5.7
Net margin
-17.4%
4.6%
0.2%
Diluted EPS
-$6.88
$1.90
$0.10
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
191
259
314
-26.5%
Capital expenditure
58.0
62.0
69.0
-6.5%
Free cash flow
133
197
245
-32.8%
Free cash flow margin
6.2%
8.8%
10.6%
Cash from investing
-45.5
-119
-84.6
Cash from financing
-63.8
-380
-478
Depreciation and amortisation
93.8
97.6
94.4
-3.9%
Share-based compensation
17.8
17.0
22.2
+4.7%
Buybacks
0.0
124
165
Dividends paid
0.0
0.0
0.0
Diluted shares, weighted
54m
54m
58m
-0.7%
Shares outstanding at period end
54m
54m
56m
+0.3%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
1,304
1,745
1,742
-25.3%
Debt
1,229
1,292
1,525
-4.9%
Operating lease liabilities
0.0
n/a
n/a
Other liabilities
888
917
922
-3.1%
Total liabilities and equity
3,421
3,953
4,189
-13.5%
Fixed assets
396
424
453
-6.6%
Goodwill
1,033
1,451
1,446
-28.8%
Intangible assets
913
1,099
1,072
-16.9%
Cash and equivalents
342
266
503
+28.2%
Receivables
206
226
224
-9.2%
Inventory
357
330
334
+8.4%
Other assets
175
157
157
+11.3%
Total assets
3,421
3,953
4,189
-13.5%
10-K for the year ended 30 September 2019, filed 26 November 2019: the filing.